Lab members are in bold, * Co-first authors, Co-corresponding authors
-
Tavernari D. , Battistello E. , Dheilly E., Petruzzella A.S., Mina M. , Sordet-Dessimoz J.,
Peters S., Krueger T., Gfeller D., Riggi N., Oricchio E., Letovanec I.
and Ciriello G. (2021) Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression . Cancer Discovery, 11, 1490-1507
-
Mina M., Iyer A., Tavernari D., Raynaud F. and Ciriello G. (2020)
Discovering functional evolutionary dependencies in human cancers .
Nature Genetics, 52, 1198-1207
Highlights:
- "Evolutionary dependencies show paths to cancer development" Martin S. Taylor, Nat. Genetics
-
Featured in Nature Cancer Milestones
-
Dheily, E.*, Battistello E.*, Katanayeva N., Sungalee S., Michaux, J., Duns G., Wehrle S., Sordet-Dessimoz J.,
Mina M., Racle J., Farinha P., Coukos G., Gfeller D., Mottok A., Kridel E., Correia B.E.,
Steidl C., Bassani-Stenberg M., Ciriello G., Zoete V., Oricchio E. (2020)
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma .
Cancer Cell, 5, 674-689
-
Donaldson-Collier M.C.*, Sungalee S.*, Zufferey M.*, Tavernari D.*,
Katanayeva N., Battistello E., Mina M., Douglass K., Rey T., Raynaud F., Manley S.,
Ciriello G., Oricchio E. (2019) EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within topologically associating domains.
Nature Genetics, https://doi.org/10.1038/s41588-018-0338-y
-
Zeng Q., Michael I.P, Zhang P., Saghafinia S., Knott G., Jiao W.,
McCabe B.D., Galván J.A., Robinson H.P.C., Zlobec I., Ciriello G., Hanahan D. (2019)
Synaptic proximity enables NMDAR signalling to promote brain metastasis .
Nature, 573, 526-531
-
Cheng W-C., Tsui Y-C., Ragusa S., Koelzer V.H., Mina M., Franco F., Läubli H., Tschumi B.,
Speiser D., Romero P., Zippelius A., Petrova T.V., Mertz K., Ciriello G., Ho P-C. (2019)
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle .
Nat. Immunology, 20, 206-217
-
Sanchez-Vega F.*, Mina M.*, Armenia J.*, Chatila W.K., Luna A., La K.C., Dimitriadoy S., Liu D.L., Kantheti H.S., Saghafinia S.,
Chakravarty D., Daian F., Gao Q., Bailey M.H., Liang W., Foltz S.M., Shmulevich I., Ding I., Heins Z., Ochoa A., Gross B., Gao J., Zhang H., Kundra R., Kandoth C., Bahceci I., Dervishi L., Dogrusoz U., Zhou W., Shen H., Laird P.W., Way G.P., Greene C.S., Liang H., Xiao Y., Wang C., Iavarone A., Berger A.H., Bivona T.G., Lazar A.J., Hammer G.D., Giordano T., Kwong L.N., McArthur G., Huang C., Tward A.D., Frederick M.J., McCormick F., Meyerson M., The Cancer Genome Atlas Research Network, Van Allen E.M., Cherniack A.D.,
Ciriello G., Sander C., Schultz N. (2018) Oncogenic Signaling Pathways in The Cancer Genome Atlas . Cell, 173(2), 321-337
-
Battistello E., Katanayeva N., Dheilly E., Tavernari D., Donaldson M.C., Bonsignore L., Thome-Miazza M., Christie A.L., Murakami M.A., Michielin O.,
Ciriello G., Zoete V., Oricchio E. (2018)
Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma .
Blood, 131(21), 2345-2356
- Oricchio E., Katanayeva N., Donaldson M.C., Sungalee S., Pasion J.P., Béguelin W., Battistello E., Sanghvi V.R., Jiang M., Jiang Y., Teater M., Parmigiani A., Budanov A.V., Chan F.C., Shah S.P., Kridel R., Melnick A.M., Ciriello G. and Wendel H-G. (2017) Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma, Science Trans. Med., 9, 396
- Ciriello G.*, Gatza M.L.*, Bexk A.H., Wilkerson M.D., Rhie S.K., Pastore A., Zhang H., McLellan M., Yau C., Kandoth C., Bowlby R., Shen H., Hayat S., Fieldhouse R., Lester S.C., Tse G.M.K., Factor R.E., Collins L.C., Allison K.H., Chen Y.Y., Jensen K., Johnson N.B., Oesterreich S., Mills G.B., Cherniack A., Robertson G., Benz C., Sander, C., Laird P.W., Hoadley K.A., King T.A., TCGA Research Network, Perou C.M., (2015) Comprehensive molecular portraits of invasive lobular breast cancer, Cell, 163, 2 506-519
- Oricchio E., Ciriello G., Jiang M., Boyce M.H., Schatz. J.H., Heguy A., Viale A., de Stanchina E., Teruya-Feldstein J., Bouska A., McKeithan T., Sander C., Tam W., Seshan V.E., Chan J., Chaganti R.S.K & Wendel H.G. (2014) Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J. Exp. Medicine, 211, 7, 1379-91
- Ciriello G., Miller L.M., Aksoy B.A., Senbabaoglu Y., Schultz N. & Sander C. (2013) Emerging landscape of oncogenic signatures across human cancers. Nat. Genetics, 45, 10, 1127-1133
- Ciriello G., Sinha R., Hoadley K.A., Jacobsen A.S., Reva B., Perou C.M., Sander C. & Schultz N. (2013), The molecular diversity of Luminal A breast tumors. Breast Cancer Res. Treat., 141, 3, 409-420
- Ciriello G., Cerami E.G., Sander C. & Schultz N. (2012), Mutual Exclusivity Analysis Identifies Oncogenic Network Modules. Genome Res., 22, 398-406
Supplemental Data
This article has been also highlighted in:
- The complete list of publications can be found here